Heidelberger Druckmaschinen Aktiengesellschaft (HBGRY)

CTI BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	736	364	341	564	808	410
Market Cap Growth	27.73%	6.73%	-39.47%	-30.19%	97.04%	118.96%
Enterprise Value	720	419	364	593	815	559
Last Close Price	1.09	0.53	0.55	0.89	1.41	0.69
PE Ratio	17.41	67.44	8.12	5.71	22.04	-
PS Ratio	0.26	0.15	0.13	0.21	0.33	0.18
PB Ratio	1.21	0.62	0.60	1.01	3.01	3.20
P/TBV Ratio	2.11	0.83	0.82	1.40	7.66	-
P/FCF Ratio	9.36	13.49	12.66	-	-	-
P/OCF Ratio	4.02	2.98	3.52	15.73	14.26	6352.33
EV/Sales Ratio	0.26	0.17	0.14	0.22	0.33	0.25
EV/EBITDA Ratio	3.78	3.31	2.70	4.27	7.72	7.87
EV/EBIT Ratio	6.30	5.45	4.50	6.58	40.74	-
EV/FCF Ratio	9.15	15.49	13.50	-	-	-
Debt / Equity Ratio	0.20	0.14	0.14	0.20	0.56	2.49
Debt / EBITDA Ratio	0.62	0.58	0.54	0.71	1.42	4.48
Debt / FCF Ratio	1.52	3.16	3.04	-	-	-
Asset Turnover	1.09	1.08	1.12	1.12	1.01	0.81
Inventory Turnover	1.56	1.75	1.82	1.80	1.73	1.58
Quick Ratio	0.53	0.55	0.59	0.58	0.57	0.63
Current Ratio	1.34	1.33	1.46	1.40	1.39	1.40
Return on Equity (ROE)	7.09%	0.93%	7.49%	24.07%	18.80%	-27.54%
Return on Assets (ROA)	2.84%	2.07%	2.16%	2.36%	0.52%	-0.47%
Return on Capital (ROIC)	9.45%	7.23%	7.69%	10.45%	2.97%	-2.15%
Return on Capital Employed (ROCE)	7.60%	5.40%	5.50%	6.10%	1.40%	-
Earnings Yield	5.74%	1.48%	12.32%	17.53%	4.54%	-12.28%
FCF Yield	10.69%	7.41%	7.90%	-9.05%	-0.55%	-17.10%
Buyback Yield / Dilution	3.95%	-	-	1.78%	-1.81%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.